A comparative study of Bayesian optimal interval (BOIN) design with interval 3+3 (i3+3) design for phase I oncology dose-finding trials - Zhou, Y; Li, R; Yan, F; Lee, J J; Yuan, Y (Stat Biopharm Res, 2021)